Longitudinal association of type 1 interferon-induced chemokines with disease activity in systemic lupus erythematosus

KL Connelly; R Kandane-Rathnayake; M Huq; A Hoi; M Nikpour; EF Morand

Journal article

Longitudinal association of type 1 interferon-induced chemokines with disease activity in systemic lupus erythematosus

KL Connelly, R Kandane-Rathnayake, M Huq, A Hoi, M Nikpour, EF Morand

SCIENTIFIC REPORTS | NATURE PUBLISHING GROUP | Published : 2018

DOI: 10.1038/s41598-018-20203-9

Download PDF

University of Melbourne Researchers

Molla Huq Author Medicine - St Vincent's Hospital

Mandana Nikpour Author Medicine - St Vincent's Hospital

Related Projects (1)

IMPROVING OUTCOMES IN SYSTEMIC AUTOIMMUNE DISEASE: A COLLABORATIVE AND INTERDISCIPLINARY PROGRAM OF RESEARCH

The multi-organ autoimmune diseases ‘scleroderma’ and ‘lupus’ have a profound negative impact on quality of life and life expectancy. The ov..

Grants

Funding Acknowledgements

EFM and MN have received research grants from the National Health and Medical Research Council of Australia. EFM has received research support from Astra-Zeneca, Pfizer, Bristol-Myers Squibb, Janssen, UCB, CSL, and GSK. MN has received research support from Actelion, Bayer, CSL Biotherapies, GlaxoSmithKline and Pfizer.